Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4872-4877

  Takeda, Haruna ^a   Sonoshita, Masahiro ^a   Oshima, Hiroko ^a   Sugihara, Ken Ichi ^b   Chulada, Patricia C ^c   Langenbach, Robert ^c   Oshima, Masanobu ^a   Taketo, Makoto M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDUCIBLE MICROSOMAL PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; PROSTAGLANDIN G2; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FIBROBLAST; GASTROINTESTINAL POLYPOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME INDUCTION; INTESTINAL POLYPS; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MEMBRANE PROTEINS; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STROMAL CELLS;

EID: 0041438603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Thun, M. M., Namboodiri, M. M., and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
2. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Golditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995.
3. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
4. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J. Natl. Cancer Inst., 90: 1529-1536, 1998.
5. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (pan II). J. Natl. Cancer Inst., 90: 1609-1620, 1998.
6. Oshima, M., and Taketo, M. M. COX selectivity and animal models for colon cancer. Curr. Pharm. Des., 8: 1021-1034, 2002.
7. Vane, J. R., Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New. Biol., 231: 232-235, 1971.
8. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
9. Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J. F., and O'Neill, G. Characterization of prostaglandin G/ H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tract. Gastroenterology, 111: 445-454, 1996.
10. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
11. Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G., and Lubet, R. A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis. Cancer Res., 60: 5040-5044, 2000.
12. Δ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res., 61: 1733-1740, 2001.
13. Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L-K., and Levin, B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342: 1946-1952, 2000.
14. Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., and Langenbach, R. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res., 60: 4705-4708, 2000.
15. Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J., Sessoms, A., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., and Langenbach, R. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res., 62: 3395-3401, 2002.
16. Thun, M. J., Henley, S. J., and Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacyologic, and clinical issues. J. Natl. Cancer Inst., 94: 252-266, 2002.
17. Sonoshita, M., Takaku, K., Oshima, M., Sugihara, K., and Taketo, M. M. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res., 62: 6846-6849, 2002.
18. Δ716 knockout mice. Nat. Med., 7: 1048-1051, 2001.
19. Jakobsson P-J., Thorén, S., Morgenstern, R., and Samuelsson, B. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA, 96: 7220-7225, 1999.
20. 2 biosynthesis. J. Biol. Chem., 275: 32775-32782, 2000.
21. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem., 275: 32783-32792, 2000.
22. Ogino, N., Miyamoto, T., Yamamoto, S., and Hayaishi, O. Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. J. Biol. Chem., 252: 890-895. 1977.
23. Lazarus, M., Kubata, B. K., Eguchi, N., Fujitani, Y., Urade, Y., and Hayaishi, O. Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch. Biochem. Biophys., 397: 336-341, 2002.
24. Watanabe, K., Kurihara, K., and Suzuki, T. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim. Biophys. Acta, 1439: 406-414, 1999.
25. Yoshimatsu, K., Altorki, N. K., Golijanin, D., Zhang, F., Jakobsson, P-J., Dannenberg, A. J., and Subbamaiah, K. Inducible prostaglandin E synthase is overexpressed in non-small cell lung carcinoma. Clin. Cancer Res., 7: 2669-2674, 2001.
26. Yoshimatsu, K., Golijanin, D., Paty, P. B., Soslow, R. A., Jakobsson, P-J., DeLellis, R. A., Subbaramaiah, K., and Dannenberg, A. J., Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res., 7: 3971-3976, 2001.
27. Δ716 knockout mice. Cancer Res., 57: 1644-1649, 1997.
28. Δ716 mouse intestinal polyps. Cancer Res., 62: 506-511, 2002.
29. Reddy, S. T., Tiano, H. F., Langenbach, R., Morham, S. G., and Herschman, H. R. Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. Biochem. Biophys. Res. Commun., 265: 205-210, 1999.
30. Poon, P., Smits, R., Li, C., Jagmohan-Changur, S., Kong, M., Cheon, S., Yu. C., Fodde, R., and Alman, B. A. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene, 20: 451-460, 2001.